Get The Facts About THC
GET THE FACTS ABOUT CBD
Delta 9-trans-tetrahydrocannabinol - delta-9 THC
Delta 8-trans-tetrahydrocannabinol - delta-8 THC
Is the main mind-bending ingredient of the marijuana plant. In its The given Estimates state that 70 to 100 percent of the marijuana high results from the delta-9 THC present. It occurs in almost all cannabis in concentrations that vary from traces to about 95 percent of all the cannabinoids in the sample.
The strongest strains of marijuana can contain up to 30% of the delta-9 THC- This is just the bud it does not include stems and seeds.
And
Delta 8-trans-tetrahydrocannabinol - delta-8 THC is not as potent, in fact less than 1% of the delta-9 THC is present. Its activity is slightly less than that of delta-9 THC. It may be an artefact of the extraction/analysis process. Most people use the general term THC for both the delta 8 and delta 9 THC.
Cannabidiol - CBD
Cannabidiol - CBD also occurs in almost all strains just like THC. The concentration levels vary from nil, to roughly 95 percent of the total cannabinoids present. THC and CBD are the two most naturally occurring cannabinoids. CBD is not what you would call a mind bender, in its pure form, although it does have analgesic, antibiotic and sedative properties.
For the CBD to affect someone’s high, Cannabidiod - CBD also occurs in almost all strains. Concentration range from none, to about 95 percent of the total cannabinoids present.
In order for CBD to affect the high, THC must be present in quantities ordinarily psychoactive. When the THC is combined with CBD it is stated that it can either increase or decrease the high.
CBD seems to elevate the depressant effects of the THC and slow down the excitatory effects. CBD also helps to prevent the onset of the high however it can make the high last twice as long. It is the kind of weed that takes a while to hit you but once it does it just keeps going.
Learn About All The 6 Other Active Ingrediants In Marijuana
Learn The Difference Between
Sativa and Indica Marijuana and its benefits
Sativa
​
Normally, cannabis Indica plant is small, bushy plants with wide leaves. The Indica plant can usually grow quicker and is more potent than the Sativa plant variety. The active ingredients produced from the cannabis Indica plants have higher CBD levels and lower THC counts. Which make it great for treating many illness.
Indica
​
The Marijuana plant called Sativa is opposite of its sister the Indica strains and normally grows tall and thin with narrow leaves. Sativa plants are also a lighter shade of green then their sister, the Indica strain. Sativa strains take a while longer to nuture, mature, and require more light. Medicine produced from cannabis Sativa have lower CBD percetage and higher THC levels.
The major qualities of Sativa medicinal strains include:
-
Effective for anti-anxiety
-
Effective for anti-depressant
-
Great for treating chronic pain
-
Elevates your focus and creativity
-
Elevates serotonin (a neurotransmitter involved in the regulation of learning, mood, sleep, anxiety and appetite)
-
Perfect for daytime use
The major qualities of Indica medicinal strains include:
-
Elevated levels of mental relaxation
-
Great for muscle relaxation
-
Less nauseated
-
Lower levels of acute pain
-
Increases appetite ( The Munchies)
-
Elevated levels of dopamine (a neurotransmitter that helps control the brain’s reward and pleasure centers)
-
Perfect for night time use
Medical Marijuana Research
Unfortunately, while we know there is a lot of benefits that we are finding out about Medicinal Marijuana. There is still not enough research being done on effects of Medicinal Marijuana for various disease and ailments. While there is a lot of research just starting and people are sharing their experiences with others as are pro-marijuana doctors. The medical marijuana industry needs to start doing more reseach.
Marijuana Research
A RANDOMISED CONTROLLED TRIAL OF SMOKED CANNABIS FOR CHRONIC NEUROPATHIC PAIN.
The study found that a single inhalation of 25 milligrams of 9.4% THC herbal cannabis three times daily for five days reduced the intensity of pain, improved sleep quality, reduced anxiety and was well tolerated.i
The results of this study were used in the development of the Canadian Pain Society’s Pharmacological management of chronic neuropathic pain: Revised consensus statement positioning medical cannabis as third line treatment for neuropathic pain.ii
​
iWare, M.A., Wang, T., Shapiro, S., Robinson, A. and others. (2010) Smoked Cannabis for Chronic Pain: a Randomized Controlled Trial. Canadian Medical Association Journal (CMAJ). 182:E694-E701.
iiMoulin, D.E., Boulanger, A., Clark A.J., Dao, T. and others. (2014) Pharmacological Management of Chronic Neuropathic Pain: Revised Consensus Statement from the Canadian Pain Society. Pain Research and Management. Nov-Dec; 19(6): 328–335.
A RANDOMIZED CONTROLLED TRIAL OF HERBAL CANNABIS ON CHRONIC NON-CANCER PAIN.
This was the first and largest study looking at the long term safety of medical cannabis use by patients suffering from chronic pain. Patients were given access to herbal cannabis containing 12.5% THC (CanniMed 12.0) and were followed over one year. The researchers found that patients with chronic pain who used cannabis daily for one year, when carefully monitored, did not have an increase in serious adverse events compared to pain patients who did not use cannabis. This study was published in the Journal of Pain.iii
​
iiiWare, M.A., Wang, T., Shapiro, S. and others. (2015) Cannabis for the Management of Pain: Assessment of Safety Study (COMPASS). The Journal of Pain. Vol 16. Nov 12. http://www.jpain.org/article/S1526-5900(15)00837-8/pdf
A CONTROLLED TRIAL OF SMOKED CANNABIS FOR ADHD .
A CONTROLLED TRIAL OF SMOKED CANNABIS FOR Multiple Sclerosis.
The study found that a single inhalation of 25 milligrams of 9.4% THC herbal cannabis three times daily for five days reduced the intensity of pain, improved sleep quality, reduced anxiety and was well tolerated.i
The results of this study were used in the development of the Canadian Pain Society’s Pharmacological management of chronic neuropathic pain: Revised consensus statement positioning medical cannabis as third line treatment for neuropathic pain.ii
​
iWare, M.A., Wang, T., Shapiro, S., Robinson, A. and others. (2010) Smoked Cannabis for Chronic Pain: a Randomized Controlled Trial. Canadian Medical Association Journal (CMAJ). 182:E694-E701.
iiMoulin, D.E., Boulanger, A., Clark A.J., Dao, T. and others. (2014) Pharmacological Management of Chronic Neuropathic Pain: Revised Consensus Statement from the Canadian Pain Society. Pain Research and Management. Nov-Dec; 19(6): 328–335.
The study found that a single inhalation of 25 milligrams of 9.4% THC herbal cannabis three times daily for five days reduced the intensity of pain, improved sleep quality, reduced anxiety and was well tolerated.i
The results of this study were used in the development of the Canadian Pain Society’s Pharmacological management of chronic neuropathic pain: Revised consensus statement positioning medical cannabis as third line treatment for neuropathic pain.ii
​
iWare, M.A., Wang, T., Shapiro, S., Robinson, A. and others. (2010) Smoked Cannabis for Chronic Pain: a Randomized Controlled Trial. Canadian Medical Association Journal (CMAJ). 182:E694-E701.
iiMoulin, D.E., Boulanger, A., Clark A.J., Dao, T. and others. (2014) Pharmacological Management of Chronic Neuropathic Pain: Revised Consensus Statement from the Canadian Pain Society. Pain Research and Management. Nov-Dec; 19(6): 328–335.